With 71% institutional ownership, PureTech Health plc (LON:PRTC) is a favorite amongst the big guns

In This Article:

Key Insights

  • Institutions' substantial holdings in PureTech Health implies that they have significant influence over the company's share price

  • A total of 9 investors have a majority stake in the company with 51% ownership

  • Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock

Every investor in PureTech Health plc (LON:PRTC) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 71% to be precise, is institutions. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

Because institutional owners have a huge pool of resources and liquidity, their investing decisions tend to carry a great deal of weight, especially with individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute.

In the chart below, we zoom in on the different ownership groups of PureTech Health.

View our latest analysis for PureTech Health

ownership-breakdown
LSE:PRTC Ownership Breakdown December 13th 2024

What Does The Institutional Ownership Tell Us About PureTech Health?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

We can see that PureTech Health does have institutional investors; and they hold a good portion of the company's stock. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see PureTech Health's historic earnings and revenue below, but keep in mind there's always more to the story.

earnings-and-revenue-growth
LSE:PRTC Earnings and Revenue Growth December 13th 2024

Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. It would appear that 5.8% of PureTech Health shares are controlled by hedge funds. That catches my attention because hedge funds sometimes try to influence management, or bring about changes that will create near term value for shareholders. Invesco Ltd. is currently the largest shareholder, with 17% of shares outstanding. With 6.4% and 5.8% of the shares outstanding respectively, Baillie Gifford & Co. and Lansdowne Partners Limited are the second and third largest shareholders.